Copyright Reports & Markets. All rights reserved.

Global Tuberculosis (TB) Diagnostics Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Tuberculosis (TB) Diagnostics by Type
    • 1.3.1 Overview: Global Tuberculosis (TB) Diagnostics Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type in 2024
    • 1.3.3 Culture-Based Diagnostics
    • 1.3.4 Sputum Smear Microscopy
    • 1.3.5 Rapid Molecular Diagnostics
    • 1.3.6 Others
  • 1.4 Global Tuberculosis (TB) Diagnostics Market by Application
    • 1.4.1 Overview: Global Tuberculosis (TB) Diagnostics Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Diagnostic Laboratories
    • 1.4.3 Hospitals
  • 1.5 Global Tuberculosis (TB) Diagnostics Market Size & Forecast
  • 1.6 Global Tuberculosis (TB) Diagnostics Market Size and Forecast by Region
    • 1.6.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Tuberculosis (TB) Diagnostics Market Size by Region, (2020-2031)
    • 1.6.3 North America Tuberculosis (TB) Diagnostics Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Tuberculosis (TB) Diagnostics Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size and Prospect (2020-2031)
    • 1.6.6 South America Tuberculosis (TB) Diagnostics Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Danaher
    • 2.1.1 Danaher Details
    • 2.1.2 Danaher Major Business
    • 2.1.3 Danaher Tuberculosis (TB) Diagnostics Product and Solutions
    • 2.1.4 Danaher Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Danaher Recent Developments and Future Plans
  • 2.2 Roche
    • 2.2.1 Roche Details
    • 2.2.2 Roche Major Business
    • 2.2.3 Roche Tuberculosis (TB) Diagnostics Product and Solutions
    • 2.2.4 Roche Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Roche Recent Developments and Future Plans
  • 2.3 Thermo Fisher Scientific
    • 2.3.1 Thermo Fisher Scientific Details
    • 2.3.2 Thermo Fisher Scientific Major Business
    • 2.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product and Solutions
    • 2.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.4 BD
    • 2.4.1 BD Details
    • 2.4.2 BD Major Business
    • 2.4.3 BD Tuberculosis (TB) Diagnostics Product and Solutions
    • 2.4.4 BD Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 BD Recent Developments and Future Plans
  • 2.5 Abbott
    • 2.5.1 Abbott Details
    • 2.5.2 Abbott Major Business
    • 2.5.3 Abbott Tuberculosis (TB) Diagnostics Product and Solutions
    • 2.5.4 Abbott Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Abbott Recent Developments and Future Plans
  • 2.6 Hologic
    • 2.6.1 Hologic Details
    • 2.6.2 Hologic Major Business
    • 2.6.3 Hologic Tuberculosis (TB) Diagnostics Product and Solutions
    • 2.6.4 Hologic Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Hologic Recent Developments and Future Plans
  • 2.7 Qiagen
    • 2.7.1 Qiagen Details
    • 2.7.2 Qiagen Major Business
    • 2.7.3 Qiagen Tuberculosis (TB) Diagnostics Product and Solutions
    • 2.7.4 Qiagen Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Qiagen Recent Developments and Future Plans
  • 2.8 BioMerieux
    • 2.8.1 BioMerieux Details
    • 2.8.2 BioMerieux Major Business
    • 2.8.3 BioMerieux Tuberculosis (TB) Diagnostics Product and Solutions
    • 2.8.4 BioMerieux Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 BioMerieux Recent Developments and Future Plans
  • 2.9 Hain Lifescience
    • 2.9.1 Hain Lifescience Details
    • 2.9.2 Hain Lifescience Major Business
    • 2.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Product and Solutions
    • 2.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Hain Lifescience Recent Developments and Future Plans
  • 2.10 Oxford Immunotec
    • 2.10.1 Oxford Immunotec Details
    • 2.10.2 Oxford Immunotec Major Business
    • 2.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Product and Solutions
    • 2.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Oxford Immunotec Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Tuberculosis (TB) Diagnostics Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Tuberculosis (TB) Diagnostics by Company Revenue
    • 3.2.2 Top 3 Tuberculosis (TB) Diagnostics Players Market Share in 2024
    • 3.2.3 Top 6 Tuberculosis (TB) Diagnostics Players Market Share in 2024
  • 3.3 Tuberculosis (TB) Diagnostics Market: Overall Company Footprint Analysis
    • 3.3.1 Tuberculosis (TB) Diagnostics Market: Region Footprint
    • 3.3.2 Tuberculosis (TB) Diagnostics Market: Company Product Type Footprint
    • 3.3.3 Tuberculosis (TB) Diagnostics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Tuberculosis (TB) Diagnostics Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
  • 6.2 North America Tuberculosis (TB) Diagnostics Market Size by Application (2020-2031)
  • 6.3 North America Tuberculosis (TB) Diagnostics Market Size by Country
    • 6.3.1 North America Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2031)
    • 6.3.2 United States Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
  • 7.2 Europe Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2031)
  • 7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country
    • 7.3.1 Europe Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
    • 7.3.3 France Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region
    • 8.3.1 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Region (2020-2031)
    • 8.3.2 China Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.5 India Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
  • 9.2 South America Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2031)
  • 9.3 South America Tuberculosis (TB) Diagnostics Market Size by Country
    • 9.3.1 South America Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country
    • 10.3.1 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Tuberculosis (TB) Diagnostics Market Drivers
  • 11.2 Tuberculosis (TB) Diagnostics Market Restraints
  • 11.3 Tuberculosis (TB) Diagnostics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Tuberculosis (TB) Diagnostics Industry Chain
  • 12.2 Tuberculosis (TB) Diagnostics Upstream Analysis
  • 12.3 Tuberculosis (TB) Diagnostics Midstream Analysis
  • 12.4 Tuberculosis (TB) Diagnostics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at US$ 2953 million in 2024 and is forecast to a readjusted size of USD 3977 million by 2031 with a CAGR of 4.4% during review period.
    Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
    Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
    APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
    In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
    This report is a detailed and comprehensive analysis for global Tuberculosis (TB) Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Tuberculosis (TB) Diagnostics market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Tuberculosis (TB) Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Tuberculosis (TB) Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Tuberculosis (TB) Diagnostics market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Tuberculosis (TB) Diagnostics
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Tuberculosis (TB) Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux, Hain Lifescience, Oxford Immunotec, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Tuberculosis (TB) Diagnostics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Culture-Based Diagnostics
    Sputum Smear Microscopy
    Rapid Molecular Diagnostics
    Others
    Market segment by Application
    Diagnostic Laboratories
    Hospitals
    Market segment by players, this report covers
    Danaher
    Roche
    Thermo Fisher Scientific
    BD
    Abbott
    Hologic
    Qiagen
    BioMerieux
    Hain Lifescience
    Oxford Immunotec
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Tuberculosis (TB) Diagnostics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Tuberculosis (TB) Diagnostics, with revenue, gross margin, and global market share of Tuberculosis (TB) Diagnostics from 2020 to 2025.
    Chapter 3, the Tuberculosis (TB) Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Tuberculosis (TB) Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Tuberculosis (TB) Diagnostics.
    Chapter 13, to describe Tuberculosis (TB) Diagnostics research findings and conclusion.

    Buy now